Dolby Laboratories $DLB Shares Sold by Cambiar Investors LLC

Cambiar Investors LLC lessened its stake in shares of Dolby Laboratories (NYSE:DLB) by 39.2% during the third quarter, Holdings Channel.com reports. The fund owned 68,393 shares of the electronics maker’s stock after selling 44,162 shares during the period. Cambiar Investors LLC’s holdings in Dolby Laboratories were worth $4,950,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Dolby Laboratories by 7.8% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock valued at $1,172,000 after purchasing an additional 1,146 shares in the last quarter. Campbell & CO Investment Adviser LLC boosted its stake in Dolby Laboratories by 193.2% during the second quarter. Campbell & CO Investment Adviser LLC now owns 17,275 shares of the electronics maker’s stock valued at $1,283,000 after buying an additional 11,384 shares in the last quarter. Meeder Asset Management Inc. grew its holdings in Dolby Laboratories by 787.1% during the third quarter. Meeder Asset Management Inc. now owns 27,526 shares of the electronics maker’s stock worth $1,992,000 after acquiring an additional 24,423 shares during the period. Summit Creek Advisors LLC raised its position in Dolby Laboratories by 24.9% in the third quarter. Summit Creek Advisors LLC now owns 125,034 shares of the electronics maker’s stock worth $9,049,000 after acquiring an additional 24,905 shares in the last quarter. Finally, Boston Trust Walden Corp lifted its holdings in Dolby Laboratories by 2.1% in the 2nd quarter. Boston Trust Walden Corp now owns 1,098,218 shares of the electronics maker’s stock valued at $81,554,000 after acquiring an additional 22,404 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Stock Performance

Shares of NYSE:DLB opened at $61.36 on Wednesday. The firm has a 50 day simple moving average of $65.27 and a 200 day simple moving average of $69.05. Dolby Laboratories has a 52 week low of $60.56 and a 52 week high of $89.66. The company has a market cap of $5.86 billion, a PE ratio of 23.33 and a beta of 0.88.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.29. The company had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The company’s revenue was up .7% on a year-over-year basis. During the same period in the previous year, the business earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, equities analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Tuesday, December 2nd. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio is 54.75%.

Insiders Place Their Bets

In other news, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the completion of the sale, the senior vice president directly owned 67,435 shares of the company’s stock, valued at $4,420,364.25. This represents a 4.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Yeaman sold 36,699 shares of the firm’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $66.91, for a total transaction of $2,455,530.09. Following the sale, the chief executive officer owned 114,725 shares of the company’s stock, valued at approximately $7,676,249.75. This represents a 24.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 137,120 shares of company stock worth $9,184,809 over the last quarter. Company insiders own 37.93% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DLB. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Monday, January 5th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a report on Thursday, January 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Finally, Barrington Research reduced their price objective on Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $90.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.